Recursion Pharmaceuticals

Organization

US biotechnology company using AI for drug discovery

3 stories

DeepMind CEO Demis Hassabis Pursues AI-Automated Drug Design

Anthropic Acquires Biotech Startup Coefficient Bio for Over $400 Million

Jensen Huang Envisions AI Transforming Biology Into Engineering Discipline